7
Views
2
CrossRef citations to date
0
Altmetric
Review

UV immunosuppression and cutaneous malignancies

, &
Pages 61-74 | Published online: 10 Jan 2014
 

Abstract

Skin cancer is the most common cancer in the USA with ultraviolet radiation (UVR) exposure being the major environmental risk factor. The mechanism by which UVR causes cancer is not yet clear but involves direct and indirect DNA damage, as well as local and systemic immunosuppression leading to a tumorigenic environment. At the cellular level, dermal dendritic cells, Langerhans cells, skin-infiltrating monocyte/macrophages, T lymphocytes, chemokines and cytokines participate. Dermal dendritic cells are recognized as the main antigen presenting cell of the skin. UV-induced skin-infiltrating monocytes/macrophages may be a source for these dermal dendritic cells. Langerhans cells serve an immunosuppressive role and activate regulatory T cells upon UVR damage. CD4+CD25+ regulatory T lymphocytes, upon activation by UV damage, suppress effector T lymphocyte proliferation, maturation and function, leading to decreased contact hypersensitivity responses. IL-12, a cytokine suppressed by UVR, is involved in DNA repair and is associated with decreased UV-induced immunosuppression, while IL-10, which is secreted in response to UVR, increases immunosuppression. This article will focus on current research into the mechanism of UV immunosuppression and its impact on skin cancers.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.